Costs of nine common mental disorders: Implications for curative and preventive psychiatry

Journal of Mental Health Policy and Economics

Volumn 9, Issue 4, 2006, Pages 193-200

  Smit, Filip ^a,b   Cuijpers, Pim ^a,b   Oostenbrink, Jan ^c   Batelaan, Neeltje ^a,b   de Graaf, Ron ^a   Beekman, Aartjan ^a,b  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; AGED; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CALCULATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST OF ILLNESS; DISABILITY; DYSTHYMIA; ECONOMIC ASPECT; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MOOD DISORDER; PANIC; PHYSICAL DISEASE; PREVALENCE; PRODUCTIVITY; PUBLIC HEALTH; RESOURCE ALLOCATION; SELF REPORT; SOCIAL PSYCHIATRY;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COST OF ILLNESS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NETHERLANDS; PSYCHIATRY;

EID: 33846421622     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kenler KS. Lifetime and 12-months prevalence of DSM-III-R psychiatric disorders in die United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
2. ESEMED. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 109 (suppl.): 21-27.
3. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.
4. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
5. Berto P, D'Ilario D, Ruffo P, Di Virgilio, Rizzo F. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ 2000; 3: 3-10.
6. Greenberg PE, Birnbaum HG. The economic burden of depression in the US: societal and patient perspectives. Expert Opinion Pharmacotherapy 2005; 6: 369-376.
7. Jöhnsson B, Olesen J. A review of the European studies on the economic burden of brain diseases. Eur J Health Economics. 2004; Suppl. 1, S1-S91.
8. Knerer G, Byford S, Johnson T, Seivewright H, Tyrer P. The Nottingham study of neurotic disorder: predictors of 12 year costs. Acta Psychiatr Scand 2005; 112: 224-232
9. Marciniak M, Lage MJ, Landbloom RP, Dunayevich E, Bowman L. Medical and productivity costs of anxiety disorders: case control study. Depress Anxiety 2004; 19: 112-120.
10. Hawthorne G, Cheok F, Goldney R, Fisher L. The excess cost of depression in South Australia: population-based study. Aust NZ J Psychiatry 2003; 37: 362-373.
11. Bijl RV, Van Zessen G, De Rijk C, Langedoen Y. The Netherlands Mental health Survey and Incidence Study (Nemesis): objectives and design. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 581-586.
12. Graaf R de, Bijl RV, Smit F, Ravelli A, Vollebergh W. Psychiatric and sociodemographic predictors of attrittion in a longitudinal study. Am J Epidemiol 2000; 152: 1039-47.
13. Bijl RV, Ravelli A, Van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (Nemesis). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587-595.
14. Bijl RV, De Graaf R, Ravelli A, Smit F, Vollebergh W. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population: results from the Netherlands Mental Health Survey and Incidence Study (Nemesis). Soc Psychiatry Psychiatr Epidemiol 2002; 37: 372-379.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition) (DSM-IV). Washington, DC: APA. 1994.
16. Ter Smitten MH, Smeets RMW, Van den Brink W. Composite International Diagnostic Interview (CIDI), version 2.1, 12-months (in Dutch). Amsterdam/Geneva: World Health Organization, 1998.
17. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 1994; 28: 57-84.
18. Central Bureau of Statistics (CBS) Gezondheidsenquêtes vragenlijst [Health Survey Inquiry]. Voorburg: CBS, 1989.
19. Hakkaart-Van Roijen L, Van Straten A, Donker M, Arendts L. Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC-P, in Dutch). Rotterdam: Erasmus University, 2002,
20. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Manual for Costing: Methods and standard costs for economic evaluations in health care (in Dutch). Diemen: Health Insurance Board, 2004.
21. Langley PC. The November 1995 revised Australian Guidelines for the economic evaluation of pharmaceuticals. Pharmacoeconomics 1996; 9: 341-352.
22. Siegel JE, Torrance GW, Russel LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies. Pharmacoeconomics 1997;11: 159-168.
23. Torrance GW, Blaker D, Destky A, Kennedy W. Canadian guidelines for economic evaluation of pharmaceuticals. Pharmacoeconomics 1996; 9: 535-559.
24. StataCorp. Stata Statistical Software, release 7.0. College Station, Texas: StataPress, 2001.
25. ESEMED Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 109 (suppl.): 39-46.
26. Löthgren M. Economic evidence in anxiety disorders: a review. Eur J Health Economics 2004; Suppl. 1: S20-S24.
27. Thomas CM, Morris S. Costs of depression among adults in England, 2000. Br J Psychiatry 2003; 183: 514-519.
28. Greenberg, PE, Sisitsky T, Kessler RC. Finkelstein SN, Berndt ER, Davidson JP, Ballenger JC, Fyer AJ.. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999; 60: 427-435.
29. Van den Brink M, Van den Hout WB, Stiggelbout AM, Van de Velde C, Kievit J Cost measurement in economic evaluations of health care: whom to ask? Med Care 2004; 42: 740-746.
30. Brower WBF, Koopmanschap MA, Rutten FFH. Productivity losses without absence: measurement validation and empirical evidence. Health Policy 1999; 48: 13-27.
31. Kessler RC, Frank R. The impact of psychiatric disorders on work loss days. Psychol Med 1997; 17: 861-873.
32. Lim D, Sanderson K, Andrews G. Lost productivity among full-time workers with mental disorders. J Ment Health Policy Economics 2000; 3: 139-146
33. Andlin-Sobocki P. Economic evidence in addiction: a review. Eur J Health Economics 2004; Suppl. 1, S4-S10.
34. Salvador-Carulla L, Seguí J, Fernández-Cano P, Canet J. Costs and offset effect in panic disorders. Br J Psychiatry 1995; 166 (suppl. 27): 23-28.
35. Löthgren M. Economic evidence in affective disorders: a review. Eur J Health Economics 2004a; Suppl. 1: S1-S19.
36. Andrews G, Issakidis C, Sanderson K. Corry J, Lapsley H. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004; 184: 526-533.
37. Cuijpers P, Van Straten A, Smit F. Preventing the incidence of new cases of mental disorders: a meta-analytic review. J Nerv Ment Dis 2005; 193: 119-125.
38. Willemse G, Smit F, Cuijpers P, Tiemens B. Minimal contact psychotherapy for sub-threshold depression in primary care: a randomised trial. Br J Psychiatry 2004; 185: 416-421.
39. Lynch FL, Hombrook M, Clarke GN, Perrin N, Polen MR, O'Connor E, Dickerson J. Cost-effectiveness of an Intervention to Prevent Depression in At-Risk Teens. Arch Gen Psychiatry 2005; 62: 1241-1248.
40. Smit F, Ederveen A, Cuijpers P, Deeg D, Beekman A. Opportunities for cost-effective prevention of late-life depression: an epidemiological approach. Arch Gen Psychiatry 2006; 63: 290-296.
41. Smit F, Willemse G, Koopmanschap M, Onrust S, Cuijpers P, Beekman A. Cost-effectiveness of preventing depression in primary care patients: randomised trial. Br J Psychiatry 2006; 188: 330-336.